David N. Chernoff

Crescendo Bioscience, Inc. develops and commercializes quantitative blood tests for rheumatoid arthritis and other autoimmune diseases. It develops quantitative, objective, reproducible blood tests to provide rheumatologists with deeper clinical insight to help enable more effective management of patients with autoimmune and inflammatory diseases. The company was founded by Mike B. Centola and Christopher L. Sutton in July 2002 and is headquartered in South San Francisco, CA.

Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA.

Part of Bayer AG, Chiron Diagnostics Corp. is a company that develops medical diagnostic products. The company is based in East Walpole, MA. Chiron Diagnostics was acquired by Bayer AG from Chiron Corp. on November 30, 1998 for $1,100 million.

Tethys Bioscience was dedicated to the discovery, development and commercialization of novel biological markers biomarkers that provided a practical tool to address the growing global challenge of chronic metabolic diseases such as diabetes. By developing new tests that used protein and other blood borne biomarkers to identify people at high risk for devastating and preventable diseases, they can arm patients and physicians with knowledge they can use to help prevent disease progression. These biomarkers gave a snapshot of an individual's current risk, which may be modifiable. Their goal was to provide clinicians with an objective and convenient means to risk-stratify their patients and help them focus appropriate intervention strategies on those most likely to benefit. Their research strategies lead to sets of biomarkers that can be used to quantify the level of an individual's risk. The company had become a pioneer in the discovery, development and value creation of novel biological markers for the clinical diagnostics marketplace: The company had built expertise, created significant intellectual property, and was executing its business plan around three key areas: Biomarker Discovery, Clinical Validation and ValueCreation. It was focused upon introducing products that yield significant savings to the health care system and improve the quality of life for patients.

Schiff Nutrition International, Inc. operates as a nutritional supplement company which offers vitamins, nutrition supplements and nutrition bars in the U. S. and abroad. Its portfolio consists of brands, including, MegaRed, Move Free, Airborne, Tiger's Milk, Sustenex, Digestive Advantage and Schiff vitamins. The company also manufactures and distributes private label products which include specialty supplements, vitamins and minerals, such as joint care products, Vitamin B and Calcium Citrate. Schiff Nutrition International was founded in 1940 and is headquartered in Salt Lake City, UT.

Pulse Health LLC provides non-invasive medical devices. It offers Revelar, an aldehyde measurement system that detects and measures aldehydes in the breath and its product through a network of distributors and independent sales agents. The company was founded by David A. Urman in 2006 and is headquartered in Lake Oswego, OR.